We are live on
!
Find out more
BG
BlackRock Group Portfolio holdings
AUM
$210B
1-Year Est. Return
15.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.81%
1 Year Est. Return
+15.5%
3 Year Est. Return
+34.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$186B
AUM Growth
-$1.28B
(-0.68%)
Cap. Flow
-$2.98B
Cap. Flow
% of AUM
-1.6%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
2,978
New
110
Increased
1,386
Reduced
1,151
Closed
137
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$296M |
| 2 |
AGN
Allergan plc
AGN
|
+$253M |
| 3 |
Walmart Inc
WMT
|
+$120M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$107M |
| 5 |
MBLY
Mobileye N.V.
MBLY
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$591M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$410M |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$161M |
| 4 |
Freeport-McMoran
FCX
|
+$147M |
| 5 |
Pfizer
PFE
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.86% |
| 2 | Financials | 13.96% |
| 3 | Technology | 13.7% |
| 4 | Industrials | 8.79% |
| 5 | Communication Services | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
2551
DELISTED
Array Biopharma Inc
ARRY
| $148K | ﹤0.01% |
20,171
-423,267
| -95% | -$3.01M |
|
|
CPHR
2552
DELISTED
Cipher Pharmaceuticals Inc.
CPHR
| $148K | ﹤0.01% |
16,317
+6,452
| +65% | +$81K |
|
2553
Cohu
COHU
$2.39B
| $145K | ﹤0.01% |
13,232
+2,901
| +28% | +$32.8K |
|
2554
Perdoceo Education
PRDO
$1.9B
| $144K | ﹤0.01% |
28,665
+2,691
| +10% | +$15.5K |
|
|
MIK
2555
DELISTED
Michaels Stores, Inc
MIK
| $144K | ﹤0.01% |
5,347
-63,043
| -92% | -$1.68M |
|
|
CLMS
2556
DELISTED
Calamos Asset Management, Inc.
CLMS
| $144K | ﹤0.01% |
10,651
-5,573
| -34% | -$71.9K |
|
2557
Argan
AGX
$7.98B
| $142K | ﹤0.01% |
3,913
| – | – |
|
2558
Geron
GERN
$911M
| $142K | ﹤0.01% |
37,723
+13,342
| +55% | +$45.3K |
|
|
PGN
2559
DELISTED
PARAGON OFFSHORE PLC (GBR)
PGN
| $142K | ﹤0.01% |
109,190
-162,054
| -60% | -$341K |
|
|
CBR
2560
DELISTED
CIBER Inc.
CBR
| $139K | ﹤0.01% |
33,801
+3,367
| +11% | +$12.6K |
|
|
SN
2561
DELISTED
Sanchez Energy Corporation
SN
| $137K | ﹤0.01% |
10,544
+1,472
| +16% | +$18K |
|
|
PERY
2562
DELISTED
Perry Ellis International Inc
PERY
| $137K | ﹤0.01% |
5,926
-81
| -1% | -$1.94K |
|
2563
Altisource Portfolio Solutions
ASPS
$65.4M
| $136K | ﹤0.01% |
1,329
+52
| +4% | +$8.66K |
|
2564
Coty
COTY
$2.33B
| $136K | ﹤0.01% |
5,638
+3,257
| +137% | +$70K |
|
2565
Kforce
KFRC
$983M
| $136K | ﹤0.01% |
6,118
+3,062
| +100% | +$71.2K |
|
2566
Modine Manufacturing
MOD
$12.8B
| $135K | ﹤0.01% |
10,001
+4,849
| +94% | +$62.5K |
|
2567
Sonida Senior Living
SNDA
$1.97B
| $135K | ﹤0.01% |
347
-51
| -13% | -$18.8K |
|
|
VCO
2568
DELISTED
Vina Concha Y Toro 50 Shrs
VCO
| $135K | ﹤0.01% |
3,276
-2,500
| -43% | -$97.1K |
|
2569
Smith & Wesson
SWBI
$655M
| $134K | ﹤0.01% |
13,718
+9,097
| +197% | +$87K |
|
|
DPLO
2570
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $134K | ﹤0.01% |
3,881
-43,279
| -92% | -$1.18M |
|
|
BLPH
2571
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
| $133K | ﹤0.01% |
+969
| New | +$151K |
|
|
ESI
2572
DELISTED
ITT EDUCATIONAL SERVICES INC
ESI
| $133K | ﹤0.01% |
19,619
-2,474
| -11% | -$19.3K |
|
2573
Sarepta Therapeutics
SRPT
$1.66B
| $132K | ﹤0.01% |
9,943
+1,812
| +22% | +$24.2K |
|
|
CEMP
2574
DELISTED
Cempra, Inc.
CEMP
| $132K | ﹤0.01% |
3,852
-740
| -16% | -$22.3K |
|
|
ALJ
2575
DELISTED
Alon USA Energy Inc
ALJ
| $131K | ﹤0.01% |
7,949
+3,587
| +82% | +$47.5K |
|
Similar funds
BA
BIM
BJ
IC
EAM
MFS
CIM
KAM
BlackRock Group's Q1 2015 Portfolio in Review
As of Q1 2015, BlackRock Group held 2,978 positions worth $186B, down 0.68% from $187B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Group's Q1 2015 filing shows 110 new, 1,386 increased, 1,151 reduced and 137 closed positions. Its largest new stake was iShares MSCI USA Size Factor ETF: 495,310 shares worth $33M. The largest sale was Allergan Inc, an estimated $591M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
- BlackRock Group's largest Q1 2015 buy was iShares MSCI USA Size Factor ETF: 495,310 shares worth $33M.
- BlackRock Group added most to Medtronic in Q1 2015, an estimated $296M increase.
- BlackRock Group's biggest Q1 2015 reduction was Freeport-McMoran, cutting an estimated $147M.
- BlackRock Group fully exited Allergan Inc in Q1 2015, selling an estimated $591M.
- BlackRock Group's ten largest holdings make up 14% of its $186B portfolio in Q1 2015.
- BlackRock Group opened 110 new positions and closed 137 in Q1 2015.
- BlackRock Group's portfolio value fell 0.68% quarter-over-quarter to $186B.
Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.